Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Selskabsmeddelelse

ScandiDos achieves EU Medical Device Regulation certification for the Delta4 Phantom+ product line

Scandidos
Download udgivelse

ScandiDos, a leading provider of patient-specific quality assurance solutions, has attained certification under the European Union Medical Device Regulation (MDR) for its quality system and Delta4 Phantom+ product line. The EU-MDR is one of the world's most robust health tech regulations, and it plays a vital role in ensuring medical devices meet the highest standards.

The MDR certification aims to enhance the safety and performance of medical devices within the EU, ensuring a high level of protection for patients and users. It imposes strict requirements on manufacturers regarding medical device design, manufacturing, and testing.

Receiving the EU's MDR certification underscores that ScandiDos' products consistently meet the highest standards, showcasing our dedication to elevating patient safety. The meticulous certification process is a testament to ScandiDos' overarching mission – to lead the industry by delivering cutting-edge solutions that set the benchmark for patient quality assurance (QA).

“Our successful compliance with the EU MDR underscores our unwavering commitment to delivering the highest quality patient QA solutions. This milestone reflects our team's dedication to meeting and exceeding regulatory standards for the benefit of patients worldwide,” says Gustaf Piehl, CEO and President, ScandiDos.

CONTACT


Gustaf Piehl, CEO, ScandiDos: investor@scandidos.com, +46 18-472 30 20
ScandiDos AB (publ), 556613-0927
Uppsala Science Park, 751 83 Uppsala

ABOUT SCANDIDOS


ScandiDos is an innovative forward-thinking company with groundbreaking software and hardware solutions for patient quality assurance in modern radiation therapy. Our Delta4 Family of products delivers a comprehensive QA solution, making the treatment process safe and efficient. We reinforce the confidence in radiotherapy clinics by providing professionals at the clinics with power and performance through independent QA.

The head office is in Uppsala Science Park, where product development is carried out. Sales are carried out by sales offices in the USA, Malaysia, and France, directly in the Nordic countries and through distributors in over 50 countries.

ScandiDos is listed on NASDAQ First North Stockholm with the ticker code SDOS. Certified adviser is Erik Penser Bank. Additional investor information can be found at Scandidos.com. Product information can be found on Delta4family.com

Attachments


ScandiDos achieves EU Medical Device Regulation certification for the Delta4 Phantom+ product line

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team